WO1988004322A1 - Artificial gravity cellular molecular injection - Google Patents

Artificial gravity cellular molecular injection Download PDF

Info

Publication number
WO1988004322A1
WO1988004322A1 PCT/US1987/003212 US8703212W WO8804322A1 WO 1988004322 A1 WO1988004322 A1 WO 1988004322A1 US 8703212 W US8703212 W US 8703212W WO 8804322 A1 WO8804322 A1 WO 8804322A1
Authority
WO
WIPO (PCT)
Prior art keywords
cells
rotor
membrane
artificial gravity
centrifuge
Prior art date
Application number
PCT/US1987/003212
Other languages
French (fr)
Inventor
Jean P. Biscar
Original Assignee
Biscar Jean P
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biscar Jean P filed Critical Biscar Jean P
Publication of WO1988004322A1 publication Critical patent/WO1988004322A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/87Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M35/00Means for application of stress for stimulating the growth of microorganisms or the generation of fermentation or metabolic products; Means for electroporation or cell fusion
    • C12M35/02Electrical or electromagnetic means, e.g. for electroporation or for cell fusion
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M35/00Means for application of stress for stimulating the growth of microorganisms or the generation of fermentation or metabolic products; Means for electroporation or cell fusion
    • C12M35/04Mechanical means, e.g. sonic waves, stretching forces, pressure or shear stimuli
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N13/00Treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves

Definitions

  • the extraction phase is completed, and the injection phase initiated, by suddenly, rapidly and continuously decreasing the angular velocity of the centrifuge rotor, and, hence, the artificial gravity field within the centrifuge chamber.
  • the resulting pressure differential across the cellular membranes induced thereby continuously forces the poration medium in proximity to the cells, now impregnate with molecules, through the pores in the cellular membranes.
  • the inflow of impregnated medium also maintains membrane porosity by preventing the membrane periphery of the pores from closing/healing, thereby allowing further inflow of impregnated medium into the cells.
  • the rate of inflow of impregnated medium, and, hence, the rate of molecular injection is controlled by adjustment of the angular deceleration of the centrifuge rotor.
  • FIG. 1 is a perspective view of a centrifuge constructed in accordance with the present invention.
  • a pair of diametrically opposed apertures 76 is formed in the peripheral edge of the disk 38 extending radially inward in the plane thereof with sufficient depth so as to intersect the central aperture 40 formed therein and penetrate through the outer cylinder 46 of the hub sub-assembly 34.
  • An electrically conductive rod 78 is internally disposed therein, having its ends secured to the peripheral wall 36 and the inner cylinder 42, respectively, upon assembly.
  • FIG. 4 additionally shows a plurality of contiguous alternating reflective and nonreflective surface markings 80 applied to the underside 54 of the rotor assembly 32.
  • the markings 80 are used in conjunction with the angular velocity indicator 20 through use of a digital optical speed sensor (not shown) .

Abstract

A method and apparatus for introducing molecules and particles inside living cells. The invention utilizes artificial gravity created by a spinning rotor. This artificial gravity produces several effects: it produces a single cell layer against the outer flat surface; it compresses the cells against the flat surface, internally pressurizing them; then an electric pulse makes an opening on the top of the cell's membranes. The subsequent acceleration of the rotor allows the controlled extraction of the cytoplasm from inside the cells; once enough cytoplasm is extracted, keeping the membrane hole open, the deceleration of the rotor, reducing the artificial gravity on the cells allows them to go back to their original shape. During this process the cells aspirate through the open membrane hole the surrounding liquid and the molecules in it to be injected into the cells. The apparatus comprises: a centrifuge and its spinning rotor, a cell chamber assembly (100) mounted on the rotor. The cell chamber assembly includes a cell chamber (140), outer and inner electrodes (104, 124) aperature (130) and passages connecting aperature (130) and cell chamber (140) and a brake mechanism for the centrifuge rotor.

Description

ARTIFICIAL GRAVITY CELLULAR MOLECULAR INJECTION
BACKGROUND OF THE INVENTION
The invention relates to in vitro injection of material into a biological entity having an exterior membrane, such as a cell, while maintaining the structure and viability of 'the biological entity.
The prior art teaches the use of microsyringes to introduce ' new molecules inside a living cell membrane. However, due to the stress incurred by the cell, such an operation is limited to one injection during the life cycle of the cell. The prior art additionally teaches use of membrane denaturing chemicals and, alternatively, "electroporation" (poration due to dielectric breakdown of particle surfaces when exposed to an direct current electric pulse) to create openings in the membranes of cells suspended in a solution heavily "doped" with the particles to be introduced therein. However, as the transport mechanism is mere diffusion, only minimal amounts of the particles penetrate the cell membrane. Neither large molecules nor electrically charged particles, such as dyes, can be successfully introduced in sufficient quantities by the diffusion mechanism. Moreover, in the case of electroporation, the pores produced thereby are quickly closed by self-healing action of the cellular membrane, thereby lowering success rates even further. And, in methods employing chemicals to achieve membrane poration, the operation is again limited to a single treatment, and even then cell viability is greatly placed at risk. SUMMARY OF THE INVENTION
It is the purpose of the instant invention to provide a method and apparatus for forced and controlled introduction of molecules into living cells without compromising cell viability.
2.'
The invention accomplishes this purpose by subjecting the cells to an artificial gravity field before, and a continuously increasing artificial gravity field during and after application of an electric field pulse, to be immediately followed by controlled decrease of the artificial gravity field. The cells are separated and flattened by the initial artificial gravity field to facilitate cellular membrane poration; the combined effect of artificial gravity a'nd electric field pulse produces simultaneous piercing of the cellular membrane; cellular membrane poration is maintained and controlled, and extraction of intracellular material enhanced and controlled, by the intracellular pressure generated in response to the increasing artificial gravity field; and positive inward flow through the a cellular membrane is induced by membrane resiliency in combination with a favorable pressure differential induced by a decreasing artificial gravity field. The controlled molecular injection is followed by natural membrane resealingr thereby ensuring cell viability. Moreover, the method may be applied several times during the life cycle of each cellr if desired.
Specifically, the method of the instant invention for injecting molecules suspended in a fluid into cells comprises the following steps: 1. A non-continuous single-thickness layer of cells is centrifugally deposited on an electrode forming the radially outward surface of a centrifuge chamber containing a poration medium of low ionic conductivity having the molecules to be injected suspended therein. The electrode surface is provided with a radius of curvature equal to ,the distance from the surface to the rotational axis of the centrifuge rotor. The arcuate electrode surface prevents undesirable lateral compression among subject cells.
2. The angular velocity of the centrifuge rotor containing a plurality of centrifuge chambers is adjusted to provide an artificial gravity field sufficient to compress the cells against the electrode forming the radially outward surface of the centrifuge chamber. Such compression causes a distortion of the normal shape of the membranes of the cells, and, as cellular volume remains essentially constant notwithstanding slight volumetric reduction due to osmosis, the cellular membrane will be placed in tension and the intracellular pressure greatly increased. The tensioning of the cellular membrane in turn facilitates poration by action of an electric field pulse, since the magnitude of the electric field pulse required to pierce the membrane is reduced by the potential energy added by artificial gravity. Moreover, the molecules to be injected into the cells migrate through the poration medium, thereby generating a high concentration of molecules in the poration medium in proximity to the cells.
3. During the porating phase, the angular velocity of the centrifuge rotor is continuously increased. The electric field pulse is produced by an electric field generated between the first electrode comprising the radially outward surface of the centrifuge chamber, and a second electrode of suitable configuration placed radially inward of the first electrode. The combined effect of artificial gravity and electric field pulse produces a simultaneous piercing of each cellular membrane along the points thereof perpendicular to the lines of the electric field.
4. Once membrane poration is achieved, the continuously increasing angular velocity of the centrifuge rotor provides an increasing artificial gravity field within the centrifuge chamber. The resulting pressure differential across the cellular membranes induced thereby continuously forces intracellular material through the pores formed in the cellular membranes. The outflow of intracellular material in turn maintains membrane porosity by preventing the membrane periphery of the pores from closing together, a pre-condition to membrane self-healing, thereby allowing further amounts of intracellular material to exit the cells. The rate of material outflow is controlled by adjustment of the angular acceleration of the centrifuge rotor.
5. The extraction phase is completed, and the injection phase initiated, by suddenly, rapidly and continuously decreasing the angular velocity of the centrifuge rotor, and, hence, the artificial gravity field within the centrifuge chamber. The resulting pressure differential across the cellular membranes induced thereby continuously forces the poration medium in proximity to the cells, now impregnate with molecules, through the pores in the cellular membranes. The inflow of impregnated medium also maintains membrane porosity by preventing the membrane periphery of the pores from closing/healing, thereby allowing further inflow of impregnated medium into the cells. The rate of inflow of impregnated medium, and, hence, the rate of molecular injection, is controlled by adjustment of the angular deceleration of the centrifuge rotor.
6. Upon maintenance of a constant rotor angular velocity, and, hence, a constant artificial gravity field, the intracellular pressure equalizes with the now constant chamber pressure, thereby eliminating any pressure differential remaining across the cellular membranes. The inflow of impregnated medium through the membrane pores ceases. The membrane periphery of the pores is thereby allowed to close, and the membranes "heal" themselves, whereby the pores are sealed.
7. The centrifuge rotor is allowed to coast to a stop, and the cells removed from the chamber by conventional means.
BRIEF DESCRIPTION OF THE DRAWINGS
FIG. 1 is a perspective view of a centrifuge constructed in accordance with the present invention.
FIG. 2 is a top view of the centrifuge rotor assembly encompassed by a solenoid-actuated band brake.
FIG. 3 is a sectional view of the rotor assembly taken along line 3-3 of FIG. 2
FIG. 4 is a bottom view of the rotor assembly of FIG. 2.
FIG. 5 is a top view of a centrifuge chamber assembly wherein cells are placed. S
FIG. 6 is a side view, broken away in part for clarity, and taken in the direction of arrow 6 of FIG. 5, of the chamber assembly of FIG. 5 engaged with the rotor assembly of FIG. 2.
FIG. 7 is an elevational view of a slip port mechanism for the addition or removal of cells from -the centrifuge chamber assembly.
FIG. 8 is an illustration of cells centrifugally deposited in a non-continuous layer upon the surface of the radially outward electrode of the chamber assembly within circle 6 of FIG. 5.
FIG. 9 is an illustration similar to that of FIG. 8 of porated cells experiencing increasing chamber hydrostatic pressure subsequent to application of electric field pulse.
FIG. 10 is an illustration similar to that of FIG. 8 of porated cells experiencing increasing chamber hydrostatic pressure subsequent to application of electric field pulse.
FIG. 11 is an illustration similar to that of FIG. 8 of subject cells whose membranes are undergoing self-healing upon the stabilization of hydrostatic pressure within the chamber.
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENT OF THE INVENTION
FIG. 1 shows a centrifuge 10 embodying the present invention. The centrifuge housing 12 includes a circular rotor chamber 14 and a control panel 16 having a rotor assembly angular velocity control knob 18, a rotor assembly angular velocity indicator 20, and a brake actuator control knob 22. An electric motor (not shown) is disposed internally of the housing 12, having a threaded shaft (not shown) formed of electrically conductive material protruding within the center of the rotor chamber 14, whereupon a rotor assembly 24 is secured. A steel band 28 comprises the peripheral surface of the rotor chamber 14. As shown in FIG. 2, the band 28 operates as a friction brake against the peripheral wall 36 of the rotor assembly 32 upon engagement therewith by ' activation of a solenoid 30, controlled by the brake actuator control knob 22.
The rotor assembly 32 shown in FIG. 2 comprises a hub sub-assembly 34, a cylindrical peripheral wall 36 sharing the same longitudinal axis therewith, and a circular disk 38 defining a continuous radially outwardly extending surface between the hub sub-assembly 34 and the peripheral wall 36, the disk 38 being concentric with, and in the plane normal to the longitudinal axis of, the hub sub-assembly 34.
Referring to FIG. 3, the hub sub-assembly 34 comprises an inner cylinder 42, formed of electrically conductive material and having a circular longitudinal threaded aperture 44; an outer cylinder 46, concentric with the first, formed of an insulating material, having a central longitudinal aperture wherein the inner cylinder 42 is press- fit, and having one end supplied with a radially outwardly extending flange 48; and a ring 50, concentric with inner cylinder 42 and outer cylinder 46, formed of electrically conductive material, having a central longitudinal aperture wherein the outer cylinder 46 is press-fit.
As seen in FIG. 2, an annular cylindrical- peripheral wall 36, formed of electrically conductive material such as steel, encompasses the entire rotor assembly 32. The peripheral wall 36 is of sufficient thickness to sustain the centrifugal forces and provide a suitably balanced rotor assembly 32.
Referring again to FIG. 3, the circular disk 38 which defines the continuous radially outwardly extending surface of the rotor assembly 32 is characteristically formed of an insulating material, such as a polymeric substance. , - A central circular aperture 40 whose longitudinal axis is normal to the plane of the disk 38 is formed therein wherein the outer cylinder 46 of the hub sub-assembly 34 is press- fit. The ring 50 of the hub sub-assembly 34 is thereby placed contiguous with both the flange 48 of the outer cylinder 46 and the underside 52 of the disk 38. After assembly, the longitudinal end of the outer cylinder 46 opposite the one supplied with flange 48 is flush with the top surface 52 of the disk 38. The longitudinal end of the inner cylinder 42, however, does protrude from the top surface 52 of the disk 38. The disk 38 in turn is press-fit into the peripheral wall 36 so that the underside 54 of the disk 38 is flush with both longitudinal ends of the peripheral wall 36.
As seen in FIG. 2, the surface of the disk 38 includes a plurality of cylindrical retaining holes 58 and 60 placed in radially-aligned pairs, with the radial distance from the longitudinal axis of the hub sub-assembly 34 remaining constant for each inner retaining hole 58 and each outer retaining hole 60 of each pair. FIG.' 3 shows each retaining hole 58 and 60 comprising a central longitudinal aperture, whose axis is parallel to that of the hub sub- assembly 34, and a cylindrical lining 62 and 64, formed of electrically conductive material, having a central long- itudinal aperture whose axis is also parallel to that of the hub sub-assembly 34. The longitudinal end of the cylindrical lining 62 and 64 nearest the top surface 52 of the disk 38 is supplied with a chamfer 66 to aid insertion of a retaining pin 114 and 116 therein.
As seen in FIG. 4, a channel 68 is formed in „the underside 54 of the disk 38, extending from each inner retaining hole 58 radially inward to a point having a diameter equal to the inner diameter of the ring 50. A wire 70 is disposed therein, having its ends secured to the inner retaining hole lining 62 and the ring 50, respectively.
As seen in FIG. 3, an aperture 72 is formed in the peripheral edge of the disk 38 at a point radially outward of each outer retaining hole 60, extending radially inward therefrom in the plane of the disk 38. The aperture 72 is of sufficient depth so as to intersect the outer retaining hole 60. A wire 74 is internally disposed therein, having its ends secured to the peripheral wall 36 and the outer retaining hole lining 64, respectively, upon assembly.
As shown in cut-out in FIG. 4, a pair of diametrically opposed apertures 76 is formed in the peripheral edge of the disk 38 extending radially inward in the plane thereof with sufficient depth so as to intersect the central aperture 40 formed therein and penetrate through the outer cylinder 46 of the hub sub-assembly 34. An electrically conductive rod 78 is internally disposed therein, having its ends secured to the peripheral wall 36 and the inner cylinder 42, respectively, upon assembly.
FIG. 4 additionally shows a plurality of contiguous alternating reflective and nonreflective surface markings 80 applied to the underside 54 of the rotor assembly 32. The markings 80 are used in conjunction with the angular velocity indicator 20 through use of a digital optical speed sensor (not shown) .
Referring to FIGS. 5 and 6, a cell chamber assembly 100 comprises a circular disk 102, defining^ a continuous radially outwardly extending surface, and a cylindrical outer wall 104, concentric and coplanar therewith. The disk 102 is characteristically formed of an insulating material, such as a polymeric substance. A shallow central circular aperture 106 whose longitudinal axis is normal to the plane of the disk 102 is formed in the underside 108 thereof, wherein the protruding longitudinal end of the inner cylinder 42 of the rotor assembly 32 is inserted, upon engagement between the cell chamber assembly 100 and the rotor assembly 32.
The underside 108 of the disk 102 is provided with a plurality of circular apertures 110 and 112, wherein cylindrical retaining pins 114 and 116, formed of an electrically conductive material, are press-fit. Each retaining pin 114 and 116 has a cylindrical projection 118 extending beyond the underside 108 of the disk 102, and the apertures 110 and 112 are so positioned so as to allow insertion of each cylindrical projection 118 into the corresponding retaining hole lining 58 and 60 of the rotor assembly 32 upon engagement thereof, thereby providing positive electrical contact therebetween.
As shown in FIG. 6, a groove 122 is formed in the longitudinal center of the circumferential surface 120 of the disk 102, wherein an annular cylindrical electrode 124 is disposed. 0-ring grooves 126 longitudinally displaced from the centered groove 122 in both directions are also formed in the circumferential surface 120 of the disk 102, and 0- rings 128 disposed therein.
A second shallow central circular aperture 130 is formed in the disk 102 on the surface 132 opposite that into which the first shallow central circular aperture 106 is formed, the cavity formed thereby being completely isolated from that of the first aperture 106.
The cylindrical outer wall 104, characteristically formed of stainless steel, has a length along its longitudinal axis equal to that of the disk 102, and its longitudinal ends are positioned flush with the surfaces 108 and 132 thereof upon assembly by press-fitting. A cell chamber 140 is thus defined by the radially inward machined surface 142 of the outer wall 104, the radially outward surface of electrode 124, and the radially outwardly extending surfaces 144 of the longitudinally centered circumferential groove 122. The outer wall 104 serves as a second electrode within the cell chamber 140, thereby allowing the generation of an electric field between the electrode 124 and the outer wall 104. A wire 146, disposed internally of the disk 102, electrically connects the outer wall 100 to the inboard end of each outer retaining pin 116. Similarly, a wire 148 electrically connects the electrode 124 to the inboard end of each inner retaining pin 114.
As shown in hidden lines in FIG. 5, a pair of parallel spaced passages 150 are provided within the disk 102 extending from the aperture 130 to the cell chamber 140. As shown in cut-out in FIG. 5, a silicone plug 152 is placed within the cell chamber 140 between the passages 150, thereby sealing the shorter circumferential chamber path between the passages 150. Fluid conducted through one of the passages 150 is thus conducted through the cell chamber 140 along the longer circumferential chamber path between the passages 150, and then out the other of the passages 150. „
As best seen in FIG. 7, a rotary slip port mechanism 160 comprises a rotary lower element 162 that is fixedly press fit into aperture 130 of the cell chamber assembly 100. The element 162 has a pair of laterally extending ports 164 and 166 that register with the passages 150 in the disk 102. The port 164 communicates with a central passage 168 and the port 166 communicates with an annular passage 170.
A fixed upper element 180 is connected to the lower element 162 by a pair of sleeves 182 and 184, each of which is press fit into the lower element 162 so as to rotate therewith. The sleeve 182 extends upwardly to define the central passage 168 which, in turn, communicates with an inlet tube 190. The sleeve 184 extends upwardly into the fixed element 180 to define the annular passage 170 which communicates with an outlet tube 192. The sleeves 182 and 184 are sealed relative to the fixed element 180 by a pair of O-riπgs 194 and 196, respectively.
Although press-fitting was employed in the assembly of the preferred embodiment disclosed hereinabove, it may be readily appreciated that any suitable fastening means may be employed to secure assembly components together.
The operation of the centrifuge 10 in accordance with the method disclosed hereinabove for extraction of the intracellular material of mammalian cells is as follows:
A sterilized cell chamber assembly 100, having a rotary slip port 160 press-fit therein, is placed in contiguous engagement with a rotor assembly 32. The rotor assembly 32 is then mounted within the rotor chamber 14„ of the centrifuge 10 upon the electrically conductive shaft of the electric motor housed therein (not shown) . An electrical signal applied to the shaft is conducted to the outer wall 104 of the cell chamber assembly 100 via the inner cylinder 42, rod 78, peripheral wall 36, wire 74, outer retaining hole lining 64, outer retaining pin 116, and wire 146. An arcless brush (not shown) is placed in contact with the ring 50 of the rotor hub sub-assembly 26 to complete the electrical circuit leading to the electrode 124 of the cell chamber assembly 100 via wire 70, inner retaining hole lining 62, inner retaining pin 114, and wire 140.
The culture medium containing the cells in suspension is mixed with a poration medium such as 0.35M sucrose in deiσnized water and a medium containing the molecules to be injected into the cells. The cells, suspended in the resultant mixture, are fed under pressure through the inlet tube 190, passage 168, port 164, and passage 150 of the cell chamber assembly 100 until the cell chamber 140 is completely filled therewith. The complete filling of the cell chamber 140 is assured when the cell and molecule suspension mixture begins to exit the outlet passage 150 of the cell chamber 100. Cells may be concomitantly removed from the cell chamber 140 through a passage 150, port 166, passage 170 and exit tube 192. It is to be noted that the centrifuge 10 of the instant invention lends itself to batch or continuous operation by use of the slip port mechanism 160.
In order to maximize the extraction of intracellular material prior to molecular injection, it is important that sufficiently few cells are introduced thereby into the cell chamber 140 so as not to form a continuous single-thickness layer on the radially inward surface 142 of the outer wall 104 (hereinafter electrode surface 142) upon centrifugation. Undesirable lateral compression of cells is thereby avoided, allowing for maximum distortion of the cellular membrane upon further centrifugation. Multiple- thickness layers of cells formed upon the electrode surface 142 must be avoided, as "point-fusion" will be generated between cells contacting along the radial lines of the cell chamber assembly 100 upon the application of an electric field pulse. Since the amplitude of electric field pulse required for cellular membrane poration greatly exceeds that required for intercellular fusion, the point-fused fusion products will be initially porated as well. As the point-fused fusion products have increased membrane surface with which to absorb the increasing hydrostatic pressure during the initial stages of the extraction phase, there would be no out-going flow of intracellular material through the pores additionally formed in the membrane. Thus, a premature healing of the of cellular membrane is likely to occur during the extraction phase, thereby preventing molecular injection into the fused cells.
Centrifugation begins as the rotor assembly 24 begins to rotate. A slow angular velocity is initially prescribed to transport the suspended cells to the electrode surface 142. The molecules are also transported by centrifugation effect towards the electrode surface 142. The amount of time required to deposit the cells against the electrode surface 142 varies inversely with square of the angular velocity of the cell chamber assembly 100.
When the cells have been deposited against the surface 108 of the outer electrode 100, and the molecules transported to the porating medium in proximity thereto, the resistivity of the porating medium may be measured by examining the resistance across the inner cylinder 34 and the ring 42, both of the hub sub-assembly 26, as they are electrically connected to the outer electrode 100 and the inner electrode 102, respectively. It will be seen that this value of medium resistivity may be used to estimate the quantity of intracellular material that has been extracted by the instant method, thereby affording instruction as to when braking for injection should be be initiated.
During the cell compression phase, the angular velocity of the rotor assembly is adjusted to a predetermined value by means of adjustment of the angular velocity control knob 18 while viewing the angular velocity indicator 20. The artificial gravity field generated by such rotation flattens the cells against the electrode surface 142. As cell volume remains essentially constant, notwithstanding slight reduction of cell volume through osmosis, the membranes of the cells will be placed in tension. This tensioning of the cellular membrane in turn facilitates membrane poration by action of an electric field pulse, since the magnitude of the pulse required to pierce the membrane is reduced thereby. As the porating phase begins, the angular velocity of the centrifuge rotor assembly 24 is gradually and continuously increased. The electric field pulse is then generated between the electrode 124 and the outer wall 104. The combined effect of artificial gravity and electric field pulse produces simultaneous piercing of each cellular membrane along the radially extending lines of the centrifuge, as illustrated in FIG. 9.
- Once membrane poration is achieved, the extraction phase begins. The continuously increasing angular velocity of the centrifuge rotor assembly 32 provides an ever increasing artificial gravity field within the cell chamber 140. The resulting pressure differential across the cellular membranes induced thereby continuously forces intracellular material through the pores formed in the cellular membranes, as illustrated by arrows in FIG. 9. The outflow of intracellular material in turn maintains cellular membrane porosity by preventing pore closure/healing, thereby allowing further quantities of intracellular material to exit the cells. The rate of extraction is ' controlled by adjustment of the angular acceleration of the cell chamber assembly 100. In that the medium containing the extricated material has greater ionic conductivity than the original porating medium, the amount of intracellular material extracted may be estimated by examining the change in the resistivity of the porating medium, as measured across the inner cylinder 42 and the ring 50, both of the rotor hub sub- assembly 34.
When the quantity of intracellular material extracted is adjudged sufficient, the extraction phase is terminated, \ 7
and the injection phase initiated, by suddenly, rapidly and continuously decreasing the angular, velocity of the cell chamber assembly 100 by frictional engagement of the brake band 28, upon actuation of the solenoid 32 by the brake actuator control knob 22. The resulting pressure differential across the cellular membranes induced thereby continuously 'forces the poration medium in proximity to the cells, now impregnate with molecules, through the. pores in the cellular membranes, as illustrated by arrows in FIG. 10. The inflow of impregnated medium also maintains membrane porosity by preventing the membrane periphery of the pores from closing/healing, thereby allowing further inflow of impregnated medium into the cells. The rate of inflow of impregnated medium, and, hence, the rate of molecular injection, is controlled by adjustment of the brake actuator control knob 22.
The injection phase is completed upon maintenance of a constant angular velocity of the cell chamber assembly 100, and, hence, a constant artificial gravity field within the cell chamber 140. The intracellular pressure equalizes with the now constant chamber pressure, thereby eliminating any pressure differential remaining across the cellular membranes. The inflow of impregnated medium through the membrane pores ceases. The membrane periphery of the pores is thereby allowed to close, and the membranes "heal" themselves, whereby the pores are sealed, as illustrated in FIG. 11.
In the final removal phase, the cell chamber assembly 100 is allowed to coast to a complete stop. The contents of the cell chamber 140 is removed therefrom by purging the cell chamber 140 by feeding culture medium under pressure into the inlet passage 150 of the cell chamber assembly 100. The angular momentum of the cells tends to cause cell shifting upon slowing of the cell chamber assembly 100, thereby helping to suspend the cells in the medium within the cell chamber 140 which in turn facilitates removal of the cells therefrom.
While the preferred embodiment of the invention has been disclosed, it should be appreciated that the invention is susceptible of modification without departing from the
spirit of the invention or the scope of the subjoined claims.

Claims

I CLAIM :
1. A method for injecting a plurality of molecules suspended in a fluid into a biological entity having an exterior membrane comprising the steps of
subjecting said entity to an artificial gravity field in an annular chamber;
applying an electric field pulse while increasing said artificial gravity field so as to open the membrane of said entity;
further increasing said artificial gravity field subsequent to application of said electric field pulse whereby a quantity of interior material is forcibly removed from said entity by a pressure differential induced across said membrane; and
rapidly decreasing said artificial gravity field, whereby said molecules are injected into said entity by a pressure differential induced across said membrane.
2. A centrifuge for producing an artificial gravity field on a biological entity having an exterior membrane to effect injection of a plurality of molecules thereinto, said centrifuge comprising
a rotor,
an annular chamber in said rotor at the periphery thereof, a first electrode in said chamber forming a radially inner surface thereof,
a second electrode in said chamber forming a radially outer surface thereof,
means for applying an electrical potential across said first and second electrodes of the chamber while said rotor is in motion to open the membrane of said entity, and
a brake for rapidly decelerating said rotor subsequent to the application of said electrical potential, whereby said molecules are injected into said entity.
PCT/US1987/003212 1986-12-07 1987-12-04 Artificial gravity cellular molecular injection WO1988004322A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US93860786A 1986-12-07 1986-12-07
US938,607 1986-12-07

Publications (1)

Publication Number Publication Date
WO1988004322A1 true WO1988004322A1 (en) 1988-06-16

Family

ID=25471664

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1987/003212 WO1988004322A1 (en) 1986-12-07 1987-12-04 Artificial gravity cellular molecular injection

Country Status (1)

Country Link
WO (1) WO1988004322A1 (en)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5612207A (en) * 1993-03-23 1997-03-18 Cbr Laboratories, Inc. Method and apparatus for encapsulation of biologically-active substances in cells
US5720921A (en) * 1995-03-10 1998-02-24 Entremed, Inc. Flow electroporation chamber and method
US6004663A (en) * 1995-03-29 1999-12-21 E. I. Du Pont De Nemours And Company Solid surface material with foam backing
US6074605A (en) * 1995-03-10 2000-06-13 Entremed, Inc. Flow electroporation chamber and method
US6582636B1 (en) 1995-03-29 2003-06-24 E. I. Du Pont De Nemours And Company Two-step process for producing solid surface material with foam backing
US6773669B1 (en) 1995-03-10 2004-08-10 Maxcyte, Inc. Flow electroporation chamber and method
US7029916B2 (en) 2001-02-21 2006-04-18 Maxcyte, Inc. Apparatus and method for flow electroporation of biological samples
US7141425B2 (en) 2001-08-22 2006-11-28 Maxcyte, Inc. Apparatus and method for electroporation of biological samples
US7771984B2 (en) 2004-05-12 2010-08-10 Maxcyte, Inc. Methods and devices related to a regulated flow electroporation chamber

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4456581A (en) * 1980-11-25 1984-06-26 Boehringer Mannheim Gmbh Centrifugal analyzer rotor unit and insert elements
US4695547A (en) * 1986-04-02 1987-09-22 Jeffrey L. Hilliard Probe for electrofusion, electroporation, or like procedure

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4456581A (en) * 1980-11-25 1984-06-26 Boehringer Mannheim Gmbh Centrifugal analyzer rotor unit and insert elements
US4695547A (en) * 1986-04-02 1987-09-22 Jeffrey L. Hilliard Probe for electrofusion, electroporation, or like procedure

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5612207A (en) * 1993-03-23 1997-03-18 Cbr Laboratories, Inc. Method and apparatus for encapsulation of biologically-active substances in cells
US5720921A (en) * 1995-03-10 1998-02-24 Entremed, Inc. Flow electroporation chamber and method
US6074605A (en) * 1995-03-10 2000-06-13 Entremed, Inc. Flow electroporation chamber and method
US6773669B1 (en) 1995-03-10 2004-08-10 Maxcyte, Inc. Flow electroporation chamber and method
US6004663A (en) * 1995-03-29 1999-12-21 E. I. Du Pont De Nemours And Company Solid surface material with foam backing
US6582636B1 (en) 1995-03-29 2003-06-24 E. I. Du Pont De Nemours And Company Two-step process for producing solid surface material with foam backing
US7029916B2 (en) 2001-02-21 2006-04-18 Maxcyte, Inc. Apparatus and method for flow electroporation of biological samples
US7141425B2 (en) 2001-08-22 2006-11-28 Maxcyte, Inc. Apparatus and method for electroporation of biological samples
US7186559B2 (en) 2001-08-22 2007-03-06 Maxcyte, Inc. Apparatus and method for electroporation of biological samples
US7771984B2 (en) 2004-05-12 2010-08-10 Maxcyte, Inc. Methods and devices related to a regulated flow electroporation chamber
US9546350B2 (en) 2004-05-12 2017-01-17 Maxcyte, Inc. Methods and devices related to a regulated flow electroporation chamber

Similar Documents

Publication Publication Date Title
US5858253A (en) Blood separation process
US4670147A (en) Disposable diagnostic plasma filter dispenser
EP0194271B1 (en) Closed hemapheresis system
EP0231623A2 (en) Couette membrane filtration apparatus for separating suspended components in a fluid medium using high shear
WO1988004322A1 (en) Artificial gravity cellular molecular injection
US3920549A (en) Method and apparatus for multiphase fluid collection and separation
US4405079A (en) Centrifugal displacer pump
US4806247A (en) Plasmapheresis system and method
EP0808203B1 (en) Centrifuge with annular filter
EP0794824B1 (en) Method and device for separating fibrin monomer from blood plasma
US6652475B1 (en) Automated blood component separation system
US4386895A (en) Apparatus for producing capsules
JP2001520570A (en) Separation set for blood component preparation
JPH0458957A (en) Plasma taking device
EP3383269B1 (en) Apparatus for preparing blood fraction concentrate
US4752284A (en) Artificial gravity intracellular molecular extraction
US3395093A (en) Centrifugal chromatography and electrophoresis device
US6946079B1 (en) Centrifugal filtration method for separating fibrin monomer from blood
US5922211A (en) Method for centrifugal particle separation, particularly for use in the biological sector
DK0779098T3 (en) Process for homogenous slurry of at least one reagent in a liquid medium as well as the substances obtained by the process
EP4032603A1 (en) Filter
KR102407040B1 (en) Container for centrifugal separation
CN113862112B (en) Microfluidic centrifugal extrusion cell transfection system and cell transfection method
Sjöstrand et al. A centrifuge head for back-and-forth centrifugation to improve specimen infiltration by viscous plastics
AU708820B2 (en) Annular assembly for centrifuge device

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): JP

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE FR GB IT LU NL SE

CFP Corrected version of a pamphlet front page
CR1 Correction of entry in section i

Free format text: IN PAT.BUL.13/88,UNDER INID (31)"PRIORITY APPLICATION NUMBER"REPLACE"938707"BY"938607"